Products for Research Use Only

Yadanzigan

CAT: 0804-HY-N10312-01Size: 1 mgDry Ice: NoHazardous: No
Product image 1
1 / 1
CAT#:0804-HY-N10312-01Size:1 mg
Selected
24/48H Stock Items & 2 to 6 Weeks non Stock Items.
Quick Request Actions
Description
Yadanzigan (YDZG) is an anti-inflammatory agent and a NLRP3 inhibitor. Yadanzigan specifically inhibits NLRP3 activation via inhibiting NF-κB pathway and Reactive Oxygen Species production. Yadanzigan also moderates LPS -induced acute lung injury (ALI) in mice[1].
CAS Number
76588-87-9
Product Name Alternative
YDZG
UNSPSC
12352005
Target
NF-κB; NOD-like Receptor (NLR) ; Reactive Oxygen Species (ROS)
Related Pathways
Immunology/Inflammation; Metabolic Enzyme/Protease; NF-κB
Field of Research
Inflammation/Immunology
Solubility
10 mM in DMSO
Smiles
CC1=C[C@H](O[C@H]2[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O2)[C@@H](O)[C@@]3(C)[C@H]1C[C@@H]4[C@]56[C@@H]3[C@@H](O)[C@H](O)[C@@](OC6)(C)[C@]5(O)[C@@H](O)C(O4)=O
Molecular Formula
C26H38O14
Molecular Weight
574.57
References & Citations
[1]Cui Y, et al. Yadanzigan, a quassinoid glucoside, attenuates NLRP3 inflammasome activation to prevent LPS-induced acute lung injury. Authorea Preprints, 2020.
Shipping Conditions
Room temperature
Scientific Category
Natural Products
Clinical Information
No Development Reported
Isoform
NLRP3

Alternative Products